Candida parapsilopsis fungemias in bone marrow transplant recipients: implications for azole prophylactic therapy

Blood. 1997 May 1;89(9):3491-2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use*
  • Bone Marrow Transplantation*
  • Candida / drug effects
  • Candida / isolation & purification
  • Candidiasis / drug therapy
  • Candidiasis / epidemiology*
  • Candidiasis / prevention & control
  • Female
  • Fluconazole / pharmacology
  • Fluconazole / therapeutic use*
  • Fungemia / drug therapy
  • Fungemia / epidemiology*
  • Fungemia / prevention & control
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Incidence
  • Itraconazole / pharmacology
  • Itraconazole / therapeutic use*
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Postoperative Complications

Substances

  • Antifungal Agents
  • Itraconazole
  • Fluconazole